Name
Avita Apteek OÜ
Registry code
14906916
VAT number
EE102240917
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
07.02.2020 (4)
Financial year
01.01-31.12
Capital
2 500.00 €
Activity
47731 - Dispensing chemist in specialised stores
5 539 820 €
-28 144 €
-1%
-
133 283 €
27
Submitted
No tax arrears
-21%
-3%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Siiri Jürgenson 23.08.1984 (40) | 100% - 2 500.00 EUR | Board member | Direct ownership | Founder |
| 2020 30.06.2021 | 2021 30.06.2022 | 2022 30.06.2023 | 2023 30.06.2024 | |
|---|---|---|---|---|
| Total Revenue | 3 223 776 € | 4 599 379 € | 5 310 707 € | 5 539 820 € |
| Net profit (loss) for the period | 1 523 € | 58 450 € | 98 953 € | -28 144 € |
| Profit Margin | 0% | 1% | 2% | -1% |
| Current Assets | 799 753 € | 866 145 € | 904 994 € | 945 831 € |
| Fixed Assets | - | - | 4 810 € | 3 467 € |
| Total Assets | 799 753 € | 866 145 € | 909 804 € | 949 298 € |
| Current Liabilities | 795 730 € | 803 672 € | 748 377 € | 816 015 € |
| Non Current Liabilities | - | - | - | - |
| Total Liabilities | - | - | - | - |
| Share Capital | - | - | - | - |
| Equity | 4 023 € | 62 473 € | 161 427 € | 133 283 € |
| Employees | 22 | 23 | 25 | 27 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 1 631 794.08 € | 91 242.68 € | 75 221.31 € | 31 |
| 2023 Q4 | 1 567 717.71 € | 81 029.35 € | 70 135.22 € | 33 |
| 2023 Q3 | 1 367 402.13 € | 73 191.02 € | 70 595.07 € | 32 |
| 2023 Q2 | 1 467 328.42 € | 80 355.52 € | 74 960.01 € | 33 |
| 2023 Q1 | 1 577 985.63 € | 76 049.85 € | 65 259.51 € | 28 |
| 2022 Q4 | 1 504 899.25 € | 79 162.49 € | 66 244.78 € | 31 |
| 2022 Q3 | 1 330 587.86 € | 70 738.1 € | 62 800.49 € | 34 |
| 2022 Q2 | 1 375 801.29 € | 68 206.93 € | 55 019.22 € | 33 |
| 2022 Q1 | 1 432 059.67 € | 67 196.25 € | 53 175.52 € | 32 |
| 2021 Q4 | 1 349 770.72 € | 57 178.71 € | 48 808.83 € | 30 |
| 2021 Q3 | 1 208 301.63 € | 64 356.54 € | 50 872.08 € | 26 |
| 2021 Q2 | 1 139 331.62 € | 56 953.93 € | 49 687.53 € | 27 |
| 2021 Q1 | 1 177 633.85 € | 59 027.22 € | 50 888.11 € | 28 |
| 2020 Q4 | 1 323 322.32 € | 56 859.81 € | 46 096.22 € | 31 |
| 2020 Q3 | 1 111 941.34 € | 55 389.29 € | 41 667.03 € | 30 |
| 2020 Q2 | 567 365.81 € | 24 536.35 € | 16 277.89 € | 29 |
| 2020 Q1 | - | - | - | 30 |
